Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi De Silva

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Visualized Experiments : Jove|July 7, 2011
Ex vivo infection of live tissue with oncolytic virusesJean-Simon Diallo, Dominic Roy, Hesham Abdelbary, et al.
Cytokine & Growth Factor Reviews|March 27, 2010
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesNaomi De Silva, Harold Atkins, David H Kirn, et al.
Cancer Gene Therapy|July 11, 2020
Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafishDavid Mealiea, Emilie Boudreau, Naomi De Silva, et al.
The Journal of Biological Chemistry|April 6, 2006
Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell deathNicoleta Hosszu Ungureanu, Mireille Cloutier, Stephen M Lewis, et al.
Molecular Therapy Oncolytics|February 4, 2022
Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockadeMitsuko Inoue, Minah Kim, Tomoyoshi Inoue, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanomaTae-Ho Hwang, Anne Moon, James Burke, et al.
Plos One|February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitorsHeather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Journal of Virology|December 11, 2012
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental gliomaMarkus J V Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, et al.
Cancer Research|December 21, 2017
Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple MechanismsMinah Kim, Maximilian Nitschké, Barbara Sennino, et al.
Cancer Research|February 9, 2013
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humansCaroline J Breitbach, Rozanne Arulanandam, Naomi De Silva, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|July 7, 2011
Ex vivo infection of live tissue with oncolytic virusesJean-Simon Diallo, Dominic Roy, Hesham Abdelbary, et al.
Cytokine & Growth Factor Reviews|March 27, 2010
Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic virusesNaomi De Silva, Harold Atkins, David H Kirn, et al.
Cancer Gene Therapy|July 11, 2020
Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafishDavid Mealiea, Emilie Boudreau, Naomi De Silva, et al.
The Journal of Biological Chemistry|April 6, 2006
Internal ribosome entry site-mediated translation of Apaf-1, but not XIAP, is regulated during UV-induced cell deathNicoleta Hosszu Ungureanu, Mireille Cloutier, Stephen M Lewis, et al.
Molecular Therapy Oncolytics|February 4, 2022
Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockadeMitsuko Inoue, Minah Kim, Tomoyoshi Inoue, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanomaTae-Ho Hwang, Anne Moon, James Burke, et al.
Plos One|February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitorsHeather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Journal of Virology|December 11, 2012
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental gliomaMarkus J V Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, et al.
Cancer Research|December 21, 2017
Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple MechanismsMinah Kim, Maximilian Nitschké, Barbara Sennino, et al.
Cancer Research|February 9, 2013
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humansCaroline J Breitbach, Rozanne Arulanandam, Naomi De Silva, et al.
Pageof 2